Reporting adverse incidents: neurostimulators
- Medicines and Healthcare products Regulatory Agency
- Part of:
- Medical devices: guidance for manufacturers on vigilance, Patient safety, Medical devices regulation and safety, and Vigilance, safety alerts and guidance
- First published:
- 1 June 2013
For manufacturers reporting adverse incidents with neurostimulators under the European vigilance system.
PDF, 46.6KB, 1 page
This file may not be suitable for users of assistive technology. Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email firstname.lastname@example.org. Please tell us what format you need. It will help us if you say what assistive technology you use.
Published: 1 June 2013